Colocalization of phosphorylated forms of WAVE1, CRMP2, and tau in Alzheimer's disease model mice: Involvement of Cdk5 phosphorylation and the effect of ATRA treatment

Journal of Neuroscience Research

Volumn 94, Issue 1, 2016, Pages 15-26

  Watamura, Naoto ^a   Toba, Junya ^a   Yoshii, Aya ^a   Nikkuni, Miyu ^a   Ohshima, Toshio ^a  

^a WASEDA UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; ATRA; CRMP2; Neurofibrillary tangle; Tau; WAVE1

Indexed keywords

COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; CYCLIN DEPENDENT KINASE 5; GLYCOGEN SYNTHASE KINASE 3BETA; NERVE PROTEIN; PROTEIN AGGREGATE; RETINOIC ACID; TAU PROTEIN; UNCLASSIFIED DRUG; WISKOTT ALDRICH SYNDROME PROTEIN FAMILY VERPROLIN HOMOLOGOUS PROTEIN 1; 6-(2-FLUOROETHOXY)-2-(2-(4-METHYLAMINOPHENIL)ETHENYL)BENZOXAZOLE; ACTIN BINDING PROTEIN; AIF1 PROTEIN, MOUSE; AMYLOID PRECURSOR PROTEIN; ANILINE DERIVATIVE; BENZOXAZOLE DERIVATIVE; CALCIUM BINDING PROTEIN; COLLAPSIN RESPONSE MEDIATOR PROTEIN-2; GLIAL FIBRILLARY ACIDIC PROTEIN; NEUROLEPTIC AGENT; PRESENILIN 1; SIGNAL PEPTIDE; WISKOTT ALDRICH SYNDROME PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BIOCHEMICAL ANALYSIS; BRAIN HOMOGENATE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS; IMMUNOREACTIVITY; MICROGLIA; MOUSE; NEURITE; NEUROFIBRILLARY TANGLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SENILE PLAQUE; ANIMAL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; NERVE CELL; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANILINE COMPOUNDS; ANIMALS; ANTIPSYCHOTIC AGENTS; BENZOXAZOLES; CALCIUM-BINDING PROTEINS; CYCLIN-DEPENDENT KINASE 5; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, TRANSGENIC; MICROFILAMENT PROTEINS; NERVE TISSUE PROTEINS; NEURITES; NEURONS; PHOSPHORYLATION; PRESENILIN-1; TAU PROTEINS; TRETINOIN; WISKOTT-ALDRICH SYNDROME PROTEIN FAMILY;

EID: 84945307161     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23674     Document Type: Article

References (43)

1. Blanchard V, Moussaoui S, Czech C, Touchet N, Bonici B, Planche M, Canton T, Jedidi I, Gohin M, Wirths O, Bayer T, Langui D, Duyckaerts C, Tremp G, Pradier L. 2003. Time sequence of maturation of dystrophic neurites associated with Aβ deposits in APP/PS1 transgenic mice. Exp Neurol 184:247-263.
2. Ceglia I, Kim Y, Nairn AC, Greengard P. 2010. Signaling pathways controlling the phosphorylation state of WAVE1, a regulator of actin polymerization. J Neurochem 114:182-190.
3. Cole AR, Noble Wendy, Van Aalten L, Plattner F, Meimaridou R, Hogan D, Taylor M, LaFrancois J, Gunn-Moore F, Verkhratsky A, Oddo S, LaFerla F, Giese KP, Dineley KT, Duff K, Richardson JC, Yan SD, Hanger DP, Allan SM, Sutherland C. 2007. Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer's disease progression. J Neurochem 103:1132-1144.
4. Corcoran JPT, So PL, Maden M. 2004. Disruption of the retinoid signalling pathway causes a deposition of amyloid beta in the adult rat brain. Eur J Neurosci 20:896-902.
5. Cuchillo-Ibanez I, Seereeram A, Byers HL, Leung KY, Ward M, Anderton BH, Hanger DP. 2008. Phosphorylation of tau regulates its axonal transport by controlling its binding to kinesin. FASEB J 22:3186-3195.
6. Cummings BJ, Su JH, Geddes JW, Van Nostrand WE, Wagner SL, Cunningham DD, W Cotman C. 1992. Aggregation of the amyloid precursor protein within degenerating neurons and dystrophic neurites in Alzheimer's disease. Neuroscience 48:763-777.
7. Dajani R, Fraser E, Roe SM, Young N, Good V, Dale TC, Pearl LH. 2001. Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition. Cell 105:721-732.
8. Dheen ST, Jun Y, Zhou Y, Tay SSW. 2005. Retinoic acid inhibits expression of TNF-α and iNOS in activated rat microglia. Glia 50:21-31.
9. Ding Y, Qiao, Wang Z, Goodwin JS, Lee ES, Block ML, Allsbrook M, McDonald MP, Fan GH. 2008. Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model. J Neurosci 28:11622-11634.
10. Fulga TA, Elson-schwab I, Khurana V, Steinhilb ML, Spires TL, Hyman BT, Feany MB. 2007. Abnormal bundling and accumulation of f-actin mediates tau-induced neuronal degeneration in vivo. Nat Cell Biol 9:139-148.
11. Germain P, Chambon P, Eichele G, Evans RM, Lazar MA, Leid M, De lera AR, Lotan Reuben, Mangelsdorf DJ, Gronemeyer H. 2006. International union of pharmacology. LXIII. Retinoid x receptors. Pharmacol Rev 58:760-772.
12. Gu Y, Hamajima N, Ihara Y. 2000. Neurofibrillary tangle-associated collapsin response mediator protein-2 (CRMP-2) is highly phosphorylated on Thr-509, Ser-518, and Ser-522. Biochemistry 39:4267-4275.
13. Guo Q, Fu W, Sopher BL, Miller MW, Ware CB, Martin GM, Mattson MP. 1999. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knockin mice. Nat Med 5:101-106.
14. Hallows JL, Chen K, Depinho RA, Vincent I. 2003. Decreased cyclin-dependent kinase 5 (cdk5) activity is accompanied by redistribution of cdk5 and cytoskeletal proteins and increased cytoskeletal protein phosphorylation in p35 null mice. J Neurosci 23:10633-10644.
15. Hashiguchi M, Saito T, Hisanaga SI, Hashiguchi T. 2002. Truncation of CDK5 activator p35 induces intensive phosphorylation of Ser202/Thr205 of human tau. J Biol Chem 277:44525-44530.
16. Hensley K, Venkova K, Christov A, Gunning W, Park J. 2011. Collapsin response mediator protein-2: an emerging pathologic feature and therapeutic target for neurodisease indications. Mol NeurobioL 43:180-191.
17. Ihara Y, Nukina N, Miura R, Ogawara M. 1986. Phosphorylated tau protein is integrated into paired helical filaments in Alzheimer's disease 1. J Biochem 99:1807-1810.
18. Iqbal K, Alonso ADC, Chen S, Chohan MO, El-Akkad E, Gong CX, Khatoon, Li B, Liu F, Rahman A, Tanimukai H, Grundke-Iqbal I. 2005. Tau pathology in Alzheimer's disease and other tauopathies. Biochi Biophys Acta 1739:198-210.
19. Itagaki P, Mcgeer L, Akiyama H, Zhu S, Seloke D. 1989. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer's disease. J Neuroimmunol 24:173-182.
20. Jankowsky JL, Slunt HH, Ratovitski T, Jenkins NA, Copeland NG, Borchelt DR. 2001. Coexpression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol Eng 17:157-165.
21. Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, Jenkins N, Copeland NG, Lee MK, Younkin LH, Wagner SL, Younkin SG, Borchelt DR. 2004. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Gen 13:159-170.
22. Kim Y, Sung JY, Ceglia I, Lee KW, Ahn JH, Halford JM, Kim AM, Kwak SP, Park JB, Ho Ryu S, Schenck A, Bardoni B, Scott JD, Nairn AC, Greengard P. 2006. Phosphorylation of WAVE1 regulates actin polymerization and dendritic spine morphology. Nature 442:814-817.
23. Kitamura Y, Shimohama S, Kamoshima W, Ota T, Matsuoka Y. 1998. Alteration of proteins regulating apoptosis, Bcl-2, Bcl-X, Bax, Bak, Bad, ICH-1, and CPP32, in Alzheimer's disease. Brain Res 780:260-269.
24. Mehya K, Mcqueen T, Tucker S, Pandita R, Aggarwalt B. 1994. Inhibition by all-trans-retinoic acid of tumor necrosis nitric oxide production by peritoneal macrophages factor. J Leukoc Biol 55:336-342.
25. Misner DL, Jacobs S, Shimizu Y, Urquiza AMD, Solomin L, Perlmann T, Luca LMD, Stevens CF. 2001. Vitamin A deprivation results in reversible loss of hippocampal long-term synaptic plasticity. Proc Natl Acad Sci U S A 98:11714-11719.
26. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, Laferla FM. 2003. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Aβ and synaptic dysfunction. Neuron 39:409-421.
27. Okamura N, Suemoto T, Shimadzu H, Suzuki M, Shiomitsu T, Akatsu H, Yamamoto T, Staufenbiel M, Yanai K, Arai H, Sasaki H, Kudo Y, Sawada T. 2004. Styrylbenzoxazole derivatives for in vivo imaging of amyloid plaques in the brain. J NeuroscI 24:2535-2541.
28. Piedrahita D, Hernández I, López-Tobón A, Fedorov D, Obara B, Manjunath BS, Boudreau RL, Davidson B, Laferla F, Gallego-Gómez JC, Kosik KS, Cardona-Gómez GP. 2010. Silencing of Cdk5 reduces neurofibrillary tangles in transgenic Alzheimer's mice. J Neurosci 30:13966-13976.
29. Plattner F, Angelo M, Peter K, Giese KP. 2006. The roles of cyclin-dependent kinase 5 and glycogen synthase kinase3 in tau hyperphosphorylation. J Biol Chem 281:25457-25465.
30. Quintanilla RA, Orellana DI, González-Billault C, Maccioni RB. 2004. Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway. Exp Cell Res 295:245-257.
31. Ren Y, Sahara N. 2013. Characteristics of tau oligomers. Front Neurol 4:1-6.
32. Saitoh T, Horsburgh K, Masliah E. 1993. Hyperactivation of signal transduction systems in Alzheimer's disease. Ann N Y Acad Sci 695:34-41.
33. Sanchez AM, Flamini MI, Fu XD, Mannella P, Giretti MS, Goglia L, Genazzani AR, Simoncini T. 2009. Rapid signaling of estrogen to WAVE1 and moesin controls neuronal spine formation via the actin cytoskeleton. Mol Endocrinol 23:1193-1202.
34. Selkoe DJ. 2000. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399:23-31.
35. Selkoe DJ. 2001. Alzheimer's disease: genes, proteins, and therapy. Physiology 81:741-766.
36. Shelton SB, Krishnamurthy P, Johnson GVW. 2004. Effects of cyclin-dependent kinase-5 activity on apoptosis and tau phosphorylation in immortalized mouse brain cortical cells. J Neurosci Res 76:110-120.
37. Takata K, Kitamura Y, Nakata Y, Matsuoka Y, Tomimoto H, Taniguchi T, Shimoham S. 2009. Involvement of WAVE accumulation in Abeta/APP pathology-dependent tangle modification in Alzheimer's disease. Am J Pathol 175:17-24.
38. Utreras E, Keller J, Terse A, Prochazkova M, Iadarola MJ, Kulkarni AB. 2012. Transforming growth factor-1 regulates cdk5 activity in primary sensory neurons. J Biol Chem 287:16917-16929.
39. Vickers JC, Chin D, Edwards AM, Sampson V, Harper C, Morrison J. 2006. Dystrophic neurite formation associated with age-related beta amyloid deposition in the neocortex: clues to the genesis of neurofibrillary pathology. Exp Neurol 11:1-11.
40. Wang J-Z, Grundke-Iqbal I, Iqbal K. 2007. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration. Eur J Neurosci 25:59-68.
41. Yamashita N, Ohshima T, Nakamura F, Kolattukudy P, Honnorat J, Mikoshiba K, Goshima Y. 2012. Phosphorylation of CRMP2 (collapsin response mediator protein 2) is involved in proper dendritic field organization. J Neurosci 32:1360-1365.
42. Yoshida H, Watanabe A, Ihara Y. 1998. Collapsin response mediator protein-2 is associated with neurofibrillary tangles in Alzheimer's disease. J Biol Chem 273:9761-9768.
43. Yoshiyama Y, Higuchi M, Zhang B, Huang S, Iwata N, Saido TC, Maeda J, Suhara T, Trojanowski JQ, Lee VM. 2007. Synapse loss and microglial activation precede tangles in a p301s tauopathy mouse model. Cell 337-351.